Treace Medical Concepts, Inc. Total Long-Term Debt
Treace Medical Concepts, Inc. (TMCI) had Total Long-Term Debt of $56.04 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2026-08-07
- 2026-06-30: Long-term Debt $56.04M.
- 2026-03-31: Long-term Debt $55.82M.
- 2025-12-31: Long-term Debt $55.58M.
- 2025-09-30: Long-term Debt $53.53M.
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $56.04M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $55.82M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $55.58M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $53.53M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $53.45M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $53.38M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $53.31M 10-K · filed 2026-02-27 |
| 2024-09-30 | $53.23M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $53.16M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $53.08M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $53.01M 10-K · filed 2025-02-27 |
| 2023-09-30 | $52.93M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $52.86M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $52.78M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $52.71M 10-K · filed 2024-02-27 |
| 2022-09-30 | $52.64M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $52.56M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $29.41M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $29.36M 10-K · filed 2023-03-08 |
| 2021-09-30 | $29.32M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $29.28M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $29.23M 10-Q · filed 2021-05-25 |
| 2020-12-31 | $30.98M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |